African mythology

"Vivid" Lives Up to Its Name

Retrieved on: 
Friday, May 14, 2021

She inadvertently comes face-to-face with a drug crisis that complicates life in her new home, and soon a series of unusual ailments befalls her children, threatening their future.\nReleased on May 4, 2021, Vivid is a compelling read that is frighteningly relevant, with vibrant characters and shades of Kate Moore\'s The Radium Girls.

Key Points: 
  • She inadvertently comes face-to-face with a drug crisis that complicates life in her new home, and soon a series of unusual ailments befalls her children, threatening their future.\nReleased on May 4, 2021, Vivid is a compelling read that is frighteningly relevant, with vibrant characters and shades of Kate Moore\'s The Radium Girls.
  • Jones spent 17 years working with various nonprofit and public service agencies across the United States.
  • A storyteller at heart, she created the Anansi Project, a creative writing program for youth and young adults which resulted in the Anansi\'s Web literary magazine.\nVivid is published by Basil Bay Press and is available for purchase on Barnes and Noble.com, Target.com and Amazon.
  • To learn more about this gem of a find, please visit JanaJJones.com/vivid.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/vivid-lives-up-to-its-name-30129...\n'

NuVasive to Participate as Double Diamond Sponsor at the 13th International Congress on Early Onset Scoliosis and Host the MAGEC® Users Meeting

Retrieved on: 
Thursday, November 14, 2019

At the same location, on November 23, 2019, NuVasive will host the fourth annual MAGEC Users Meeting.

Key Points: 
  • At the same location, on November 23, 2019, NuVasive will host the fourth annual MAGEC Users Meeting.
  • "NuVasive's involvement in ICEOS and hosting of the MAGEC Users Meeting underscores our commitment to advancing the continuum of care for pediatric patients," said Matt Link, president of NuVasive.
  • "Through our 10 years of experience with MAGEC technology, NuVasive has developed a deep understanding of the challenges associated with early onset scoliosis, and a strong appreciation of how our solutions change the lives of patients and families every day.
  • NuVasive's booth #1 at ICEOS will feature its procedural solutions for pediatric spine care, including MAGEC, the Company's proprietary magnetic adjustable growing rods for the treatment of early onset scoliosis.

GNCC Capital, Inc. - Completion Of Pending Transaction And The First Public Engagement By The Company's New Board Of Directors

Retrieved on: 
Wednesday, October 16, 2019

Your recently appointed GNCC Directors confirm that at this time, GNCC will focus its activities in South Africa through its 40% shareholding in Jengu Pharma (Pty) Limited ("Jengu").

Key Points: 
  • Your recently appointed GNCC Directors confirm that at this time, GNCC will focus its activities in South Africa through its 40% shareholding in Jengu Pharma (Pty) Limited ("Jengu").
  • Jengu through its ownership of a South African Company which is presently growing Cannabis and primarily for export.
  • It is recorded that the balance of the shares in Jengu are held directly by both Ms. Allen and Mr. Cox.
  • As previously stated, both of your Executive Directors have recognized the need to; and have committed to expend time in shareholder engagement.

Simeio Solutions Names Elizabeth Shannon as Chief of Staff

Retrieved on: 
Thursday, October 3, 2019

ATLANTA, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Simeio Solutions, the global leader in Identity and Access Management (IAM) as-a-Service, is pleased to announce Elizabeth Shannon has been appointed Chief of Staff.

Key Points: 
  • ATLANTA, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Simeio Solutions, the global leader in Identity and Access Management (IAM) as-a-Service, is pleased to announce Elizabeth Shannon has been appointed Chief of Staff.
  • Im very excited to have Elizabeth stepping into this new role, said Hemen Vimadalal, CEO at Simeio Solutions.
  • Elizabeth has a rare quality in her communication approach, and in her ability to deftly handle a myriad of issues companywide.
  • Prior to her new role as Chief of Staff, Elizabeth was integral in developing, implementing, and improving the companys systems and processes to meet its growing business needs.

NuVasive Announces UK Launch Of MAGEC® X For Early Onset Scoliosis Treatment

Retrieved on: 
Tuesday, September 18, 2018

Key aesthetic improvements, such as laser-marked sagittal bending lines, help to enhance surgeon workflow efficiency and ease of use.

Key Points: 
  • Key aesthetic improvements, such as laser-marked sagittal bending lines, help to enhance surgeon workflow efficiency and ease of use.
  • "Additionally, MAGEC X substantially improves intra-op workflow with enhanced ease of use.
  • This U.K. commercial launch of MAGEC X follows the Company's U.S. commercial launch which occurred in July 2018.
  • The Company will also host a MAGEC Users Meeting in Lisbon, Portugal on November 16, 2018, following the International Congress on Early Onset Scoliosis (ICEOS) Annual Meeting.

Nuvasive Launches MAGEC X For Early Onset Scoliosis Treatment

Retrieved on: 
Thursday, July 19, 2018

SAN DIEGO, July 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of MAGEC X, a new procedural solution within the MAGEC product family that addresses Early Onset Scoliosis (EOS).

Key Points: 
  • SAN DIEGO, July 19, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the U.S. launch of MAGEC X, a new procedural solution within the MAGEC product family that addresses Early Onset Scoliosis (EOS).
  • "Further, the upgrade of the internal components in MAGEC X rods gives me even more confidence in the performance of a system that has radically changed how we treat this challenging patient population."
  • "MAGEC X represents the culmination of over a decade of clinical experience and innovation, resulting in a stronger and smarter MAGEC implant design."
  • This full commercial launch of MAGEC X follows the Company's preview announcement, which occurred at the POSNA Annual Meeting in May in Austin, Texas.